Product
Inonotus Obliquus
1 clinical trial
10 indications
Indication
Mood DisorderIndication
Sleep DisturbanceIndication
Drug EffectIndication
healthIndication
SubjectiveIndication
Psilocin ToxicityIndication
Psilocybin PoisoningIndication
PsilocybinIndication
AnxietyClinical trial
Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyStatus: Withdrawn, Estimated PCD: 2023-08-01